Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,416,000
+$1,956,000 QoQ
Shares Held
700,000
-30.0% QoQ
Ownership
0.463%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#41
of 294 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integral Health Asset Management, LLC holds $1,502,601,600 across 54 Biotechnology names. BHVN ranks #29 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,500,000 | $280,920,000 | |
| 2 | INSM |
INSMED Inc
|
1,600,000 | $170,592,000 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,600,000 | $136,304,000 | |
| 4 | EWTX |
Edgewise Therapeutics, Inc.
|
2,000,000 | $81,260,000 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
1,750,000 | $75,092,500 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
300,000 | $73,431,000 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,000,000 | $70,780,000 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
550,000 | $61,066,500 |
All Filings in BHVN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,416,000 | 700,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,460,000 | 1,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,935,000 | 1,500,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,756,500 | 650,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,233,000 | 300,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,207,000 | 175,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||